Quynh Lam

Quynh Lam has a diverse work experience spanning across multiple industries and roles. In 2009, they started their career as a Student Intern at PerkinElmer, Inc. and later as a Student Intern at Houston Police Department Recruiting Division. Following this, they worked as a Medical Technologist at Massachusetts General Hospital from September 2009 to May 2012. In 2013, Quynh joined The Children's Hospital of Philadelphia as a Technical Specialist. From August 2014 to January 2022, they held the position of Molecular Technologist and later Laboratory Manager at Fox Chase Cancer Center. They then transitioned to DRUGSCAN, where they served as a Senior Manager in Laboratory Operations from January 2022 to April 2023. Currently, Quynh is working as an Operations Manager at Cabaletta Bio starting from April 2023.

Quynh Lam earned a Bachelor of Science degree in Molecular Genetic Technology from The University of Texas Health Science Center at Houston (UTHealth Houston) from 2008 to 2009. Quynh then pursued a Master's degree in Regulatory Affairs and Quality Assurance at Temple University from 2019 to 2021. Quynh Lam is currently enrolled at La Salle University, pursuing a Master of Business Administration (MBA) degree in Business Administration and Management, General, starting in 2023. In terms of certifications, they obtained a CAP Inspector certification from the College of American Pathologists (CAP) in January 2019. Additionally, they received an MB(ASCP)CM certification from the American Society for Clinical Pathology (ASCP) in August 2021. Furthermore, Quynh Lam earned a Drug Development certification from Temple University in July 2020 and a University of Pathology Informatics Certificate from the American Society for Clinical Pathology (ASCP) in November 2018.